Perceptive Advisors LLC Lineage Cell Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 7,236,843 shares of LCTX stock, worth $5.21 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,236,843Holding current value
$5.21 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding LCTX
# of Institutions
134Shares Held
106MCall Options Held
22.1KPut Options Held
0-
Broadwood Capital Inc New York, NY41.7MShares$30 Million1.65% of portfolio
-
Black Rock Inc. New York, NY9.56MShares$6.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.63MShares$6.22 Million0.0% of portfolio
-
Defender Capital, Llc.5.96MShares$4.29 Million1.17% of portfolio
-
Raffles Associates LP New York, NY5.49MShares$3.95 Million3.26% of portfolio
About Lineage Cell Therapeutics, Inc.
- Ticker LCTX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 169,755,008
- Market Cap $122M
- Description
- Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...